Author's posts
Biden Admin Implores States to Slow Medicaid Cuts After More Than 1M Enrollees Dropped
Secretary of Health and Human Services Xavier Becerra is asking states to make more of an effort to keep eligible Medicaid recipients enrolled. He particularly fears children losing health insurance coverage.
As Medicaid Purge Begins, ‘Staggering Numbers’ of Americans Lose Coverage
In what’s known as the Medicaid “unwinding,” states are combing through rolls to decide who stays and who goes. But the overwhelming majority of people who have lost coverage so far were dropped because of technicalities, not because officials determined they are no longer eligible.
Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
Is Paxlovid, the Covid Pill, Reaching Those Who Most Need It? The Government Won’t Say
Many public health workers are unable to see how many doses of Pfizer’s antiviral treatment are shipped to their communities and cannot tell whether vulnerable residents are filling prescriptions as often as their wealthier neighbors.
How the Test-to-Treat Pillar of the US Covid Strategy Is Failing Patients
The federal “test-to-treat” program was designed to be a one-stop shop for people to get tested for covid and to receive treatment. But as covid cases rise again, many communities have no participating locations, and website bugs make it difficult to book an appointment at the biggest participant.
It Was Already Hard to Find Evusheld, a Covid Prevention Therapy. Now It’s Even Harder.
At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.
Get the Data: Hollowed-Out Public Health System Faces More Cuts Amid Virus
We’re releasing our public health infrastructure data on Github for journalists, researchers and interested readers to use.
